Molecular basis of juvenile myelomonocytic leukemia

Abstract excerpt

Juvenile myelomonocytic leukemia (JMML) is classified as a combined myeloproliferative/myelodysplastic disease by the World Health Organization and accounts for less than 3% of all childhood hematologic malignancies.[1][1],[2][2] Children typically present at young age (median age at diagnosis: two

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acute Myeloid Leukemia Research
• Share to Histone Deacetylase Inhibitors Research
• Share to Protein Tyrosine Phosphatases